India is a major supplier of pharmaceuticals, particularly generic drugs, to the United States. Approximately 47% of all generic prescriptions in the US are filled by Indian companies. This significant supply contributes to billions of dollars in savings for the US healthcare system. However, recent discussions about reciprocal tariffs could potentially impact this trade relationship.
What Su-34 doink? Boom!
Everybody panic.